食色app下载

scroll down

* The search scope is limited to the products and news sections of this site

Recommended reading

Bayer: Encouraging results for all divisions-Agreement signed to divest Currenta and animal health businesses

Financial Results for the Third Quarter of 2019

Learn more>
image
Globally superior ophthalmic anti-VEGF drug Elias® dual indications are officially listed in the National Medical Insurance Directory

Learn more>
image

Bayer Elias® treatment interval can be extended to 3 months, and its new treatment plan is available in China

Learn more>
image

Bayer Leap plans to lead $ 215 million investment in research and development of next-generation immune tumor treatment

Learn more>
image

U.S. FDA approves darolutamide, a new treatment for non-metastatic castration-resistant prostate cancer in men

Learn more>
image

Bayer Planning Vision looks to the future of agriculture

Learn more>
image

The latest news from Bayer

Stock price / index

XETRA December 23, 2019 17:35 CEST
73.60
0.00%
DAX December 23, 2019 17:45 CEST
13,300.98
-0.13 % down -0.13%

News Center

2019-12-10

Bayer will further increase sustainable development efforts and announce comprehensive measures for sustainable development by 2030

understand more
2019-12-03

Bayer submits application of rivaroxaban for venous thromboembolism in children to European Medicines Agency

understand more
2019-12-02

Bayer China awarded "China Outstanding Employer 2020" certification

understand more

Our business

Our products are helping to solve some of today's toughest challenges, including global population growth, an aging society, and the need to be efficient-and where possible sustainable-to use natural resources.

image
image
image
image

Find what you need

Our products focus on the health of people, animals and plants. Here you can find an overview of Bayer's main products in China.

Last updated: 2019-12-17

For questions about Bayer products, you can contact us at:


Hotline: 400-810-0360 (can be dialed from mobile phones)


We will try our best to answer your inquiries about Bayer products, but we are unable to make specific diagnosis and treatment recommendations for the patient's current condition. If you experience discomfort after taking this medicine, be sure to see your doctor promptly.


If you need to report discomfort or product quality issues after using Bayer products, you can contact your doctor's pharmacist or local drug regulatory authority, or you can contact us directly by


Email: AE_China@bayer.com
Online report: http://safetrack-public.bayer.com


If you encounter adverse reactions during the use of Bayer Animal Health and Veterinary Medicine products, you can contact us through the following methods:


Email: pv.bsah@bayer.com


shut down